Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON40449
NL-OMON40449
Completed
Not Applicable

Adipose Tissue Imaging in Patients with Type 2 Diabetes, Pilot Study - AT imaging in T2D, pilot

niversitair Medisch Centrum Sint Radboud0 sites15 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionstype 2 diabetes10018424

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
type 2 diabetes
Sponsor
niversitair Medisch Centrum Sint Radboud
Enrollment
15
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
niversitair Medisch Centrum Sint Radboud

Eligibility Criteria

Inclusion Criteria

  • •Age\>\= 18 years
  • •For healthy volunteers: Fasting blood glucose\< 6\.1 mmol/l, HbA1c\< 42 mmol/mol (6%)
  • •For patients with T2D: Clinical overt T2D, on a glucose\-lowering diet or on oral glucose\-lowering medication, stable and under control for minimal 2 years, HbA1c\< 75 mmol/mol (9%)

Exclusion Criteria

  • •Renal dysfunction with MDRD\< 60
  • •Overt symptomatic neuropathy or proliferative retinopathy
  • •A history of cardiovascular disease complications (myocardial infarction, stroke, peripheral artery disease)
  • •Pregnancy or lactating
  • •Receiving subcutaneous insulin
  • •Incapability to provide informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Adipose Tissue Imaging in Type 2 DiabetesDiabetes Mellitus Type 2
NCT02528695Radboud University Medical Center15
Unknown
Not Applicable
Adipose Tissue Dysfunction in Type 2 Diabetes and Its Reversibility by Bariatric SurgeryAdipose Tissue Dysfunction Type 2 Diabetes Mellitus Bariatric Surgery
NCT05291013Odense University Hospital45
Terminated
Not Applicable
Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or InsulinType 2 Diabetes
NCT00159211Assistance Publique - Hôpitaux de Paris28
Active, not recruiting
Phase 1
Kidney Fat in Type 2 Diabetes and the Effects of EzetimibeType 2 diabetes, diabetic kidney diseaseMedDRA version: 21.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861MedDRA version: 21.1Level: LLTClassification code 10045250Term: Type II diabetes mellitus with renal manifestationsSystem Organ Class: 100000004857Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
EUCTR2020-001155-40-DKSteno Diabetes Center Copenhagen120
Not yet recruiting
Not Applicable
Study of serum adiponectin levels in type2 diabetes mellitus patients on treatment
CTRI/2022/01/039750kasturba medical college